| Targeting inflammation in metabolic syndrome FK Welty, A Alfaddagh, TK Elajami Translational Research 167 (1), 257-280, 2016 | 283 | 2016 |
| Inflammation and cardiovascular disease: From mechanisms to therapeutics A Alfaddagh, SS Martin, TM Leucker, ED Michos, MJ Blaha, ... American Journal of Preventive Cardiology, 100130, 2020 | 194 | 2020 |
| Evaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review R Ferraro, JM Latina, A Alfaddagh, ED Michos, MJ Blaha, SR Jones, ... Journal of the American College of Cardiology 76 (19), 2252-2266, 2020 | 83 | 2020 |
| Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial A Alfaddagh, TK Elajami, H Ashfaque, M Saleh, BR Bistrian, FK Welty Journal of the American Heart Association 6 (12), e006981, 2017 | 82 | 2017 |
| Eicosapentaenoic and docosahexaenoic acids attenuate progression of albuminuria in patients with type 2 diabetes mellitus and coronary artery disease TK Elajami, A Alfaddagh, D Lakshminarayan, M Soliman, M Chandnani, ... Journal of the American Heart Association 6 (7), e004740, 2017 | 49 | 2017 |
| Regression of human coronary artery plaque is associated with a high ratio of (18‐hydroxy‐eicosapentaenoic acid+ resolvin E1) to leukotriene B4 FK Welty, F Schulte, A Alfaddagh, TK Elajami, BR Bistrian, M Hardt The FASEB Journal 35 (4), e21448, 2021 | 44 | 2021 |
| An omega-3 fatty acid plasma index≥ 4% prevents progression of coronary artery plaque in patients with coronary artery disease on statin treatment A Alfaddagh, TK Elajami, M Saleh, D Mohebali, BR Bistrian, FK Welty Atherosclerosis 285, 153-162, 2019 | 39 | 2019 |
| Adherence to ACC/AHA Performance Measures for Myocardial Infarction in Six Middle-Eastern Countries: Association with In-Hospital Mortality and Clinical Characteristics JC Longenecker, A Alfaddagh, M Zubaid, W Rashed, M Ridha, F Alenezi, ... International journal of cardiology 167 (4), 1406-1411, 2013 | 26 | 2013 |
| The effect of eicosapentaenoic and docosahexaenoic acids on physical function, exercise, and joint replacement in patients with coronary artery disease: A secondary analysis of … A Alfaddagh, TK Elajami, M Saleh, M Elajami, BR Bistrian, FK Welty Journal of clinical lipidology 12 (4), 937-947. e2, 2018 | 22 | 2018 |
| Nutritional knowledge among Kuwaiti college students A Al-Isa, A Alfaddagh Health 2014, 2014 | 20 | 2014 |
| Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A … M Zubaid, H Khraishah, B Alahmad, W Rashed, M Ridha, F Alenezi, ... Annals of Global Health 86 (1), 2020 | 19 | 2020 |
| Sex disparities in the presentation, management and outcomes of patients with acute coronary syndrome: insights from the ACS QUIK trial H Khraishah, B Alahmad, A Alfaddagh, SY Jeong, N Mathenge, ... Open Heart 8 (1), 2021 | 18 | 2021 |
| Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention K Kapoor, A Alfaddagh, NJ Stone, RS Blumenthal Journal of clinical lipidology 15 (4), 545-555, 2021 | 15 | 2021 |
| Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA K Kapoor, A Alfaddagh, M Al Rifai, DL Bhatt, MJ Budoff, K Nasir, M Miller, ... Journal of the American Heart Association 10 (11), e021431, 2021 | 15 | 2021 |
| Clinical characteristics and outcomes of young adults with first myocardial infarction: Results from Gulf COAST A Alfaddagh, H Khraishah, W Rashed, G Sharma, RS Blumenthal, ... IJC Heart & Vasculature 31, 100680, 2020 | 15 | 2020 |
| Diastolic blood pressure predicts coronary plaque volume in patients with coronary artery disease M Saleh, A Alfaddagh, TK Elajami, H Ashfaque, H Haj-Ibrahim, FK Welty Atherosclerosis 277, 34-41, 2018 | 12 | 2018 |
| Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis R Quispe, A Alfaddagh, B Kazzi, F Zghyer, FA Marvel, RS Blumenthal, ... Current atherosclerosis reports 24 (7), 571-581, 2022 | 11 | 2022 |
| Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention A Alfaddagh, K Kapoor, ZA Dardari, DL Bhatt, MJ Budoff, K Nasir, M Miller, ... Atherosclerosis 353, 11-19, 2022 | 8 | 2022 |
| The ABCs of primary cardiovascular prevention: 2019 update A Alfaddagh, K Arps, RS Blumenthal, SS Martin J Am Coll Cardiol, 2019 | 8 | 2019 |
| Summarizing 2019 in Cardiovascular Prevention Using the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease’s ‘ABC’s Approach DI Feldman, R Dudum, A Alfaddagh, FA Marvel, ED Michos, ... American Journal of Preventive Cardiology, 100027, 2020 | 7 | 2020 |
Tarec K ElajamiBeth Israel Deaconess Medical CenterVerified email at bidmc.harvard.edu
